Ribosomal RACK1 Regulates the Dendritic Arborization by Repressing FMRP Activity

Int J Mol Sci. 2022 Oct 6;23(19):11857. doi: 10.3390/ijms231911857.

Abstract

FMRP is an RNA-binding protein that represses the translation of specific mRNAs. In neurons, its depletion determines the exaggerated translation of mRNAs leading to dendritic and axonal aberrant development, two peculiar features of Fragile X syndrome patients. However, how FMRP binds to translational machinery to regulate the translation of its mRNA targets is not yet fully understood. Here, we show that FMRP localizes on translational machinery by interacting with the ribosomal binding protein, Receptor for Activated C Kinase 1 (RACK1). The binding of FMRP to RACK1 removes the translational repressive activity of FMRP and promotes the translation of PSD-95 mRNA, one specific target of FMRP. This binding also results in a reduction in the level of FMRP phosphorylation. We also find that the morphological abnormalities induced by Fmr1 siRNA in cortical neurons are rescued by the overexpression of a mutant form of RACK1 that cannot bind ribosomes. Thus, these results provide a new mechanism underlying FMRP activity that contributes to altered development in FXS. Moreover, these data confirm the role of ribosomal RACK1 as a ribosomal scaffold for RNA binding proteins.

Keywords: FMRP; RACK1; neuroblastoma; neuron differentiation; neurons; ribosomes; translation.

MeSH terms

  • Fragile X Mental Retardation Protein* / genetics
  • Fragile X Mental Retardation Protein* / metabolism
  • Fragile X Syndrome* / genetics
  • Humans
  • Neoplasm Proteins / metabolism
  • Neuronal Plasticity
  • RNA, Messenger / metabolism
  • RNA, Small Interfering
  • Receptors for Activated C Kinase* / genetics
  • Receptors for Activated C Kinase* / metabolism
  • Ribosomal Proteins / metabolism
  • Ribosomes / metabolism

Substances

  • FMR1 protein, human
  • Neoplasm Proteins
  • RACK1 protein, human
  • RNA, Messenger
  • RNA, Small Interfering
  • Receptors for Activated C Kinase
  • Ribosomal Proteins
  • Fragile X Mental Retardation Protein

Grants and funding

This research was funded by National Health Institute grant number R15NS098389 to KW, FRAXA Foundation 2021 to A.B., PRIN2020 2020JF3R9K to D.C.